Severe asthma: when nature’s natural defences work against us

Delivering potentially transformational medicines through R&D innovation in Oncology

How do you test medicines in the real world?

For decades, randomised clinical trials have been a cornerstone of pharmaceutical science, reassuring patients that their medicines have been thoroughly tested. But there’s a wide world beyond the research clinic doors and the data collected in these highly controlled environments are just the first chapter of a rich story.

Inclusive design: making our differences invisible

Great design is almost invisible, it’s something that is seamless and frictionless. But for anyone who has experienced poor design, the frustration and hardship are all too evident.

Unravelling the mysteries of the human genome with functional genomics

What is functional genomics technology and how can we use it to improve our chances of finding the right targets for potential medicines?

Why collaboration is essential to achieving new breakthroughs in vaccines

Emmanuel Hanon, Senior Vice President R&D at GSK Vaccines shares how one idea combined with the right type of collaboration could change the future of vaccine development.

Tackling tomorrow’s health challenges today

From eucalyptus toothpaste to a brew for the flu: tailoring products to different tastes

STEM – inspiring tomorrow’s science and engineering superstars

Meet this year’s GSK UK Young Scientist and Engineers of the Year.

We need more women in science to create the inclusive technologies of the future

Nidhi Aggarwal, Global Packaging Development Manager, Consumer Healthcare, tells how she reached her current role and explains why we need more diversity of thought in science and applied fields.

Severe asthma: when nature’s natural defences work against us

Around 36 million people around the world are living with severe asthma. But, hope could be on the horizon thanks to a better understanding of how certain blood cells malfunction.

COPD is more than a lung disease

Ruth Tal-Singer works in respiratory research and development. Here she shares her unique perspective on how the future of COPD treatment is changing.

Using the immune system to fight cancer

From bench to bedside: lessons in converting science into impact

How a chance encounter led to a world-first toothpaste

Did you know that NovaMin, one of the key technologies in our toothpaste, is actually a bioactive glass most commonly used to repair bones?

TB: uniting scientists to tackle one of the world’s biggest killers

Tuberculosis (TB) is one of the top ten causes of deaths worldwide. We have taken a major step towards finding a potential new vaccine against the disease.

Inside the Open Lab

How does the Tres Cantos Open Lab offer top international scientists and academics the opportunity to pursue their own projects as part of an integrated team?

The vaccines of tomorrow

Join our leading scientists as they go behind the science of vaccine technology.

You, me and 23andMe: discovering new medicines through genetics

How do consumer insights fuel our innovation?

How genomics is driving a new era of drug discovery

We’re in a new era of drug discovery because of a fundamental change in our understanding of human biology.

How are we redefining research in HIV?

Shari Gordon works in the HIV Cure Center in North Carolina, a public-private company with one goal: discovering a cure for HIV/AIDS.

Following the journey of a respiratory medicine

Elaine Jones explains how her passion for helping respiratory patients live every breath motivates her in developing new medicines.

Lupus: the search for a cure continues

Doctors and their patients face an ongoing battle to manage this chronic and sometimes debilitating and life-threatening condition. See how we’re trying to help.

COPD for John just means doing everything at a slower pace

Making the Ellipta® inhaler a reality

Overcoming the challenges of COPD to fulfil a lifelong dream

Joan an 85 year old COPD patient recently achieved her lifelong dream to climb the Great Wall of China. Her daughter Helen tells us Joan’s story.

The science of shopping

Every day millions of consumers use our products. Different countries have different needs and consumers’ shopping habits vary hugely.

I control my asthma, it doesn’t control me

Jamie from our Montrose site tells how he managed his asthma to conquer Mount Kenya

Thank you for calling GSK. Meet Paul, the voice at the end of the line.

When you call us, who’s the voice at the end of the line? Paul tells his story from scientist to sympathetic ear.

You'll outgrow some childhood habits, but vaccination is for life

How curious minds saved a medicine from being left in the lab

Does lupus really know no boundaries?

There are no boundaries when it comes to the impact of lupus; it can affect any part of the body in any way at any time, often with unpredictable and life-changing results.

Giving a bit back – Christine’s experience of clinical research

For Christine even gentle exercise like jogging and walking her dogs around the park were a struggle. She just could not breathe properly.

30 years and counting: the fight against HIV

How to find a treatment for a disease with no idea what that disease actually is.

The digitalisation lab: bringing the digital age to manufacturing

We are developing world-class manufacturing innovation to help us bring medicines and consumer healthcare products to people.

COPD: Our relentless pursuit for better breathing

Getting on target in autoimmune diseases

How smart is your inhaler?

As we investigate new treatments, the ‘internet of things,’ is allowing us to explore the benefits of interconnectivity and the rich patient data that these technologies can provide.

Can social media help us hear patients?

Understanding the benefits and risks of medicine from a patient’s point of view is important to the evaluation of our medicines.

Don’t forget the pharmacists

Dr. Sharmila Ramachandran and Dr. Aruni Mulgirigama talk about the essential role of pharmacists in asthma care

Scientists or detectives? Seeking new clues in COPD

It is now widely accepted that COPD is not a uniform disease, but effects of the disease can impact people differently.

Inhaler innovation: more than a simple piece of plastic

The design behind the device

An 'everyday' world first in clinical trials

The way we design and carry out clinical trials is being turned on its head by the advent of the Salford Lung Study (SLS).

Turning the tide on antibiotic resistance

Picture a world where people routinely die from minor infections. With an alarming rise in antibiotic resistance in recent years, this almost unthinkable scenario could be a reality.

Vaccine manufacture: it’s complicated

Vaccine manufacture can take anywhere between 6 and 26 months. That’s not to mention the time required to research and develop a new vaccine, which can take up to 30 years.

Beyond manufacturing in Chile and Madagascar

GSK Vaccines sent two vaccine manufacturing teams to South America and Africa to better understand the impact of their daily work.

Living with lupus – a patient perspective

Turbocharging the effect of vaccines

Outgrowing asthma

Why is it that some people, particularly children, grow out of their asthma? That’s a question our scientists are asking as part of our research to better understand the disease.

Targeting the immune system through open innovation

A functioning immune system is crucial to our health - but what is its role beyond such things as keeping colds at bay and fighting infections?

Cell and gene therapy: a new era of medicine

If we can pinpoint a faulty gene and correct it, could we potentially find a way to cure genetic diseases?

Neuroscience: on the brain

The number of people living with dementia worldwide is set to treble by 2050 to 135 million, according to the World Health Organization.

Eggs in manufacturing